Evidence map›Paper›PMID 21534086›Full record

ReviewJournal of toxicology and environmental health. Part B, Critical reviews2011

Pulmonary endpoints (lung carcinomas and asbestosis) following inhalation exposure to asbestos.

Brooke T Mossman, Morton Lippmann, Thomas W Hesterberg, Karl T Kelsey, Aaron Barchowsky, James C Bonner

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of toxicology and environmental health. Part B, Critical reviews, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed
18.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 216 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Bioinspired particle engineering for non-invasive inhaled drug delivery to the lungs.Materials science & engineering. C, Materials for biological applications · 2021
    Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Malignant pleural mesothelioma: an update.Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia · 2021
    Review

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 1 country.

Brooke T MossmanDepartment of Pathology, University of Vermont College of Medicine, Burlington, Vermont 05405, USA. brooke.mossman@uvm.edu
Morton Lippmann
Thomas W Hesterberg
Karl T Kelsey
Aaron Barchowsky
James C Bonner
John Brown University · USNavistar International (United States) · USNorth Carolina State University · USNYU Langone Health · USUniversity of Pittsburgh · USUniversity of Vermont · US

Funding

The Epidemiology of Molecular Alterations in MesotheliomaR01CA126939 · NCI · BROWN UNIVERSITY · PI KELSEY, KARL TIMOTHY · 2008 to 2012
$2.4M
NCI NIH HHS R01 CA126939
6 · The paper itself

Abstract

Lung carcinomas and pulmonary fibrosis (asbestosis) occur in asbestos workers. Understanding the pathogenesis of these diseases is complicated because of potential confounding factors, such as smoking, which is not a risk factor in mesothelioma. The modes of action (MOA) of various types of asbestos in the development of lung cancers, asbestosis, and mesotheliomas appear to be different. Moreover, asbestos fibers may act differentially at various stages of these diseases, and have different potencies as compared to other naturally occurring and synthetic fibers. This literature review describes patterns of deposition and retention of various types of asbestos and other fibers after inhalation, methods of translocation within the lung, and dissolution of various fiber types in lung compartments and cells in vitro. Comprehensive dose-response studies at fiber concentrations inhaled by humans as well as bivariate size distributions (lengths and widths), types, and sources of fibers are rarely defined in published studies and are needed. Species-specific responses may occur. Mechanistic studies have some of these limitations, but have suggested that changes in gene expression (either fiber-catalyzed directly or by cell elaboration of oxidants), epigenetic changes, and receptor-mediated or other intracellular signaling cascades may play roles in various stages of the development of lung cancers or asbestosis.

Indexed as

AnimalsAsbestosAsbestosisBiological TransportBody BurdenCarcinogens, EnvironmentalCarcinomaChemical PhenomenaHumansInhalation ExposureLungLung NeoplasmsMineral FibersMutagensParticulate MatterTissue DistributionAsbestosCarcinogens, EnvironmentalMineral FibersMutagensParticulate Matter

Identifiers

PMID21534086
PMCPMC3118517
OpenAlexW2062155569

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.